azathioprine has been researched along with varenicline in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Allorge, D; Broly, F; Colombel, JF; Cortot, A; Jouet, JP; Torres, J; Tremblay, L | 1 |
| Barkema, HW; Clement, F; Coward, S; Ghosh, S; Heitman, SJ; Kaplan, GG; Leung, YP; Negron, M; Panaccione, R; Seow, C | 1 |
1 review(s) available for azathioprine and varenicline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for azathioprine and varenicline
| Article | Year |
|---|---|
Thiopurine S-methyltransferase deficiency associated with a novel mutation.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Benzazepines; Crohn Disease; Heterozygote; Humans; Male; Mesalamine; Methyltransferases; Mutation; Neutrophils; Nicotinic Agonists; Prednisolone; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2010 |
Funding a smoking cessation program for Crohn's disease: an economic evaluation.
Topics: Adult; Azathioprine; Benzazepines; Canada; Cost-Benefit Analysis; Crohn Disease; Directive Counseling; Female; Humans; Immunosuppressive Agents; Male; Models, Statistical; Nicotinic Agonists; Program Evaluation; Quality-Adjusted Life Years; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tumor Necrosis Factor-alpha; Varenicline | 2015 |